Skip to main content
Article
A Double-Blind, Randomized, Placebo Controlled Trial of Ramelteon for the Treatment of Insomnia and Mood Stability in Patients with Euthymic Bipolar Disorder
Research
  • Edward Norris, MD, FAPM, Lehigh Valley Health Network
Publication/Presentation Date
1-1-2007
Abstract
The study was a single-site, double-blind, randomized, placebo-controlled, parallel group study to evaluate the efficacy of adjunctive ramelteon in the treatment of insomnia and mood stability in patients with euthymic bipolar disorder for up to 24 weeks of maintenance treatment. Participants with euthymic bipolar disorder and sleep disturbances were randomized to receive adjunctive ramelteon or placebo in addition to their reular psychiatric medications for up to 24 weeks or until they experienced a relapse (defined as a depressed or manic event).
Comments

Study completed October 2007 through August 2009

Document Type
Research
Funder

Takeda Pharmaceuticals North America, Inc.

Citation Information

http://scholarlyworks.lvhn.org/psychiatry/19/

Norris, E., Karen, B., Correll, J., Zemanek, K., Lerman, J., Primelo, R., & Kaufmann, M. (2013). A double-blind, randomized, placebo-controlled trial of adjunctive ramelteon for the treatment of insomnia and mood stability in patients with euthymic bipolar disorder. Journal Of Affective Disorders, 144(1-2), 141-147.

PMID:22963894

http://search.ebscohost.com/login.aspx?direct=true&db=mnh&AN=22963894&site=ehost-live&scope=site